Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AN-PEP on Gluten Exposure in Celiac Disease
NCT04788797Phase 4Completed
- Sponsor
- Hospital de Gastroenterología Dr. Carlos Bonorino Udaondo
- Start
- Mar 2021
- Primary completion
- Jul 2022
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of GliadinX in celiac disease, sponsored by Hospital de Gastroenterología Dr. Carlos Bonorino Udaondo. Started Mar 2021; status: completed.
02
Drugs
GliadinX
03
Conditions
celiac disease
Beyond the preview
Go deeper on NCT04788797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04788797.